On July 22, Oklo Inc. rose 5.64% in pre-market trading, trading at $46.0 per share, with turnover of $2.36 million, extending momentum from the prior session's 5.11% gain.

On the news front, the nuclear power supply chain is experiencing a triple resonance driven by fuel price increases, capital expansion, and rising demand, lifting the sector broadly. At the company level, Oklo's Groves Isotope Test Reactor in Texas has received approval of the documented safety analysis from the US Department of Energy, representing the facility's final safety basis. Only two steps remain — readiness review and startup approval — before the facility is authorized to load nuclear fuel and conduct startup testing. The company is targeting first criticality for Groves within July.

Additionally, Oklo recently signed a letter of intent with Centrus Energy for high-assay low-enriched uranium supply to support its planned 1.2-gigawatt campus, with deliveries starting in 2029. The company also completed acquisitions of ARMEC and Creative Engineers to strengthen vertical integration in reactor and fuel manufacturing. Multiple catalysts continue to drive shares higher.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)